Clinical Trial Update: Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine [Phase 4]

View source ↗

Summary

Phase 4 bioequivalence study comparing two test products with one reference product, all containing 5 mg yohimbine; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Reference product containing yohimbine 5 mg (yohimbine)
• Test product 1 containing yohimbine 5 mg (yohimbine)
• Test product 2 containing yohimbine 5 mg (yohimbine)

Snippet

Sponsor: Walter Ritter GmbH & Co | Conditions: Erectile Dysfunction | Phase 4 | Status: COMPLETED